| Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications |
17 |
| An update on the recent advances in antifibrotic therapy |
16 |
| The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis |
16 |
| Sarcopenia and chronic liver diseases |
16 |
| Pancreas volume in health and disease: a systematic review and meta-analysis |
15 |
| Obesity, diabetes, and the gut microbiome: an updated review |
14 |
| Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis |
12 |
| An overview of walled-off pancreatic necrosis for clinicians |
12 |
| Hand-foot skin reaction is a beneficial indicator of sorafenib therapy for patients with hepatocellular carcinoma: a systemic review and meta-analysis |
11 |
| Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers |
11 |
| Microbial modulation of the gut microbiome for treating autoimmune diseases |
11 |
| Helicobacter pylori drug resistance: therapy changes and challenges |
11 |
| Clinical relevance of liver histopathology and different histological classifications of NASH in adults |
10 |
| Acute-on-chronic liver failure in chronic hepatitis B: an update |
10 |
| The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal |
10 |
| Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: a systematic review |
10 |
| Esophageal achalasia: current diagnosis and treatment |
10 |
| The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review |
10 |
| Health benefits of Mediterranean diet in nonalcoholic fatty liver disease |
10 |
| Adverse events in IBD therapy: the 2018 update |
10 |
| Microbiota and mucosal defense in IBD: an update |
9 |
| Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer |
9 |
| Advances in understanding the role of cytokines in inflammatory bowel disease |
9 |
| The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery |
9 |
| Elastography methods for the non-invasive assessment of portal hypertension |
9 |
| How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease |
9 |
| Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice |
9 |
| Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease |
8 |
| Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis |
8 |
| A critical appraisal of the use of ultrasound in hepatic steatosis |
8 |
| Metoclopramide for the treatment of diabetic gastroparesis |
8 |
| An update on dietary consideration in inflammatory bowel disease: anthocyanins and more |
8 |
| Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations |
8 |
| Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study |
8 |
| New insights into the role of vitamin D in hepatocellular carcinoma |
8 |
| Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease |
7 |
| The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury |
7 |
| Updates in the field of non-esophageal gastroesophageal reflux disorder |
7 |
| Fecal microbiota transplantation for managing irritable bowel syndrome |
7 |
| Pediatric NAFLD: an overview and recent developments in diagnostics and treatment |
7 |
| The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs |
7 |
| Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis |
7 |
| Pathophysiology of diverticular disease |
6 |
| Challenges of surgical management of intrahepatic cholangiocarcinoma |
6 |
| Precision medicine for metastatic colorectal cancer: an evolving era |
6 |
| Emerging treatments for short bowel syndrome in adult patients |
6 |
| Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years |
6 |
| Glucagon like peptide-2 and neoplasia; a systematic review |
6 |
| Pneumococcal vaccination in celiac disease |
5 |
| Updates in the field of autoimmune pancreatitis: a clinical guide |
5 |
